Literature DB >> 17359901

RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery).

C Parker, N Clarke, J Logue, H Payne, C Catton, H Kynaston, C Murphy, R Morgan, C Morash, W Parulekar, M Parmar, C Savage, J Stansfeld, M Sydes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17359901     DOI： 10.1016/j.clon.2007.01.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  26 in total

1.  Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Authors:  Robert B Den; Kasra Yousefi; Edouard J Trabulsi; Firas Abdollah; Voleak Choeurng; Felix Y Feng; Adam P Dicker; Costas D Lallas; Leonard G Gomella; Elai Davicioni; R Jeffrey Karnes
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Authors:  William U Shipley; Wendy Seiferheld; Himanshu R Lukka; Pierre P Major; Niall M Heney; David J Grignon; Oliver Sartor; Maltibehn P Patel; Jean-Paul Bahary; Anthony L Zietman; Thomas M Pisansky; Kenneth L Zeitzer; Colleen A F Lawton; Felix Y Feng; Richard D Lovett; Alexander G Balogh; Luis Souhami; Seth A Rosenthal; Kevin J Kerlin; James J Dignam; Stephanie L Pugh; Howard M Sandler
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

3.  Positive surgical margins after radical prostatectomy: What should we care about?

Authors:  Caroline Pettenati; Yann Neuzillet; Camelia Radulescu; Jean-Marie Hervé; Vincent Molinié; Thierry Lebret
Journal:  World J Urol       Date:  2015-05-05       Impact factor: 4.226

4.  pT3N0M0 prostate cancer: a plea for adjuvant radiation.

Authors:  Michel Bolla; Laurence Collette
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

Review 5.  The status of surgery in the management of high-risk prostate cancer.

Authors:  Christian Bach; Sailaja Pisipati; Datesh Daneshwar; Mark Wright; Edward Rowe; David Gillatt; Raj Persad; Anthony Koupparis
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

6.  Postoperative radiotherapy in prostate cancer: Analysis of prognostic factors in a series of 282 patients.

Authors:  Giuseppina Apicella; Debora Beldì; Giansilvio Marchioro; Sara Torrente; Sara Tunesi; Corrado Magnani; Alessandro Volpe; Carlo Terrone; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-01

7.  Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.

Authors:  Mark V Mishra; Eli D Scher; Jocelyn Andrel; Andrew C Margules; Sarah E Hegarty; Edouard J Trabulsi; Terry Hyslop; Robert B Den; Costas D Lallas; Leonard G Gomella; Adam P Dicker; Timothy N Showalter
Journal:  Am J Clin Oncol       Date:  2015-02       Impact factor: 2.339

8.  Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.

Authors:  J N Nyarangi-Dix; J Steimer; T Bruckner; H Jakobi; S A Koerber; B Hadaschik; J Debus; M Hohenfellner
Journal:  World J Urol       Date:  2017-08-31       Impact factor: 4.226

9.  Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.

Authors:  T M Morgan; S R Hawken; K R Ghani; D C Miller; F Y Feng; S M Linsell; J A Salisz; Y Gao; J E Montie; M L Cher
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

10.  Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

Authors:  William L Hwang; Rahul D Tendulkar; Andrzej Niemierko; Shree Agrawal; Kevin L Stephans; Daniel E Spratt; Jason W Hearn; Bridget F Koontz; W Robert Lee; Jeff M Michalski; Thomas M Pisansky; Stanley L Liauw; Matthew C Abramowitz; Alan Pollack; Drew Moghanaki; Mitchell S Anscher; Robert B Den; Anthony L Zietman; Andrew J Stephenson; Jason A Efstathiou
Journal:  JAMA Oncol       Date:  2018-05-10       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.